These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30485733)

  • 1. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
    Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
    Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H
    Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
    Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior Treatment with Anti-High Mobility Group Box-1 Antibody Boosts Human Neural Stem Cell Transplantation-Mediated Functional Recovery After Spinal Cord Injury.
    Uezono N; Zhu Y; Fujimoto Y; Yasui T; Matsuda T; Nakajo M; Abematsu M; Setoguchi T; Mori S; Takahashi HK; Komiya S; Nishibori M; Nakashima K
    Stem Cells; 2018 May; 36(5):737-750. PubMed ID: 29517828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
    Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
    Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
    PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
    Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
    Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury.
    Shibata R; Nagoshi N; Kajikawa K; Ito S; Shibata S; Shindo T; Khazaei M; Nori S; Kohyama J; Fehlings MG; Matsumoto M; Nakamura M; Okano H
    J Neurotrauma; 2022 May; 39(9-10):667-682. PubMed ID: 35196890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
    Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
    Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
    Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
    Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
    Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of induced pluripotent stem cell-derived motor neuron progenitor cells with irradiated brain-derived neurotrophic factor over-expressing engineered mesenchymal stem cells enhanced restoration of axonal regeneration in a chronic spinal cord injury rat model.
    Kim JW; Kim J; Lee SM; Rim YA; Sung YC; Nam Y; Kim HJ; Kim H; Jung SI; Lim J; Ju JH
    Stem Cell Res Ther; 2024 Jun; 15(1):173. PubMed ID: 38886817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
    Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
    PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Spinal Oligodendrogenic Neural Progenitor Cells Promote Functional Recovery After Spinal Cord Injury by Axonal Remyelination and Tissue Sparing.
    Nagoshi N; Khazaei M; Ahlfors JE; Ahuja CS; Nori S; Wang J; Shibata S; Fehlings MG
    Stem Cells Transl Med; 2018 Nov; 7(11):806-818. PubMed ID: 30085415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells.
    Kajikawa K; Imaizumi K; Shinozaki M; Shibata S; Shindo T; Kitagawa T; Shibata R; Kamata Y; Kojima K; Nagoshi N; Matsumoto M; Nakamura M; Okano H
    Mol Brain; 2020 Sep; 13(1):120. PubMed ID: 32883317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells.
    Fujimoto Y; Abematsu M; Falk A; Tsujimura K; Sanosaka T; Juliandi B; Semi K; Namihira M; Komiya S; Smith A; Nakashima K
    Stem Cells; 2012 Jun; 30(6):1163-73. PubMed ID: 22419556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
    Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
    Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice.
    Kong D; Feng B; Amponsah AE; He J; Guo R; Liu B; Du X; Liu X; Zhang S; Lv F; Ma J; Cui H
    Stem Cell Res Ther; 2021 Mar; 12(1):172. PubMed ID: 33706803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury.
    Shibata T; Tashiro S; Nakamura M; Okano H; Nagoshi N
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.